Minimally Invasive Nasal Trabeculostomy: Long-Term Follow-Up Extension Study

Sanoculis Ltd36 enrolled

Overview

This study is a follow-up extension study conducted in continuation of the prior MINT study (MMS-EEU-4), in which the long-term (i.e., 18, 24 months) clinical outcomes of Minimally Invasive Nasal Trabeculostomy (MINT) will be explored.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Open Angle Glaucoma

Interventions

Minimally Invasive Micro TrabeculostomyDEVICE

The MINT system is a surgical device designed to create a trabeculostomy within the eye.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 85 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Male or female ≥ 18 years to ≤ 85 years old 2. Subject who underwent MINT, and surgery was performed not earlier than 18 months from enrollment

Locations (1)

S. Malayan Eye Center

Yerevan, Armenia

Outcomes

Primary Outcomes

Intraocular Pressure Measurement

Observed IOP at long-term timepoints

Time frame: 18 months +/- 2 months post-MINT surgery from previous study (MMS-EEU-4).

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.